Authors:
STASI R
BRUNETTI M
PARMA A
DIGIULIO C
TERZOLI E
PAGANO A
Citation: R. Stasi et al., THE PROGNOSTIC VALUE OF SOLUBLE INTERLEUKIN-6 RECEPTOR IN PATIENTS WITH MULTIPLE-MYELOMA, Cancer, 82(10), 1998, pp. 1860-1866
Authors:
STASI R
DELPOETA G
VENDITTI A
MASI M
STIPA E
COX MC
AMADORI S
Citation: R. Stasi et al., PROGNOSTIC VALUE OF CYTOGENETICS AND MULTIDRUG-RESISTANCE (MDR1) IN ELDERLY PATIENTS WITH ACUTE MYELOID-LEUKEMIA, Blood, 92(2), 1998, pp. 695-696
Authors:
STASI R
VENDITTI A
DELPOETA G
CONFORTI M
BRUNETTI M
BUSSA S
AMADORI S
PAGANO A
Citation: R. Stasi et al., ROLE OF HUMAN-LEUKOCYTE INTERFERON-ALPHA IN THE TREATMENT OF PATIENTSWITH POLYCYTHEMIA-VERA, The American journal of the medical sciences, 315(4), 1998, pp. 237-241
Authors:
STASI R
BRUNETTI M
BUSSA S
CONFORTI M
DIGIULIO C
CRESCENZI A
TERZOLI E
VECCHIONE A
PAGANO A
Citation: R. Stasi et al., RESPONSE TO RECOMBINANT-HUMAN-ERYTHROPOIETIN IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES, Clinical cancer research, 3(5), 1997, pp. 733-739
Authors:
STASI R
BRUNETTI M
BUSSA S
VENDITTI A
DELPOETA G
CONFORTI M
SCIMO MT
CUDILLO L
ADORNO G
CECCONI M
AMADORI S
PAGANO A
Citation: R. Stasi et al., EFFICACY AND SAFETY OF HUMAN-LEUKOCYTE INTERFERON-ALPHA TREATMENT IN PATIENTS YOUNGER THAN 60 YEARS OF AGE WITH POLYCYTHEMIA-VERA, Journal of internal medicine, 242(2), 1997, pp. 143-147
Authors:
BRUNO A
BALLATORE G
ADORNO G
CARAVITA T
VENDITTI A
DELPOETA G
STASI R
BUCCISANO F
SANTINELLI S
PICARDI A
CALUGI A
TRIBALTO M
AMADORI S
Citation: A. Bruno et al., RED-BLOOD-CELL DEPLETION AND CRYOPRESERVATION OF UMBILICAL-CORD BLOOD(UCB), Bone marrow transplantation, 20(1), 1997, pp. 89-90
Authors:
STASI R
BRUNO A
VENDITTI A
DELPOETA G
ARONICA G
COX MC
MAFFEI L
CATALANO G
ZANGRILLI D
AMADORI S
Citation: R. Stasi et al., A MICROGRANULAR VARIANT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH ATYPICALMORPHO-CYTOCHEMICAL FEATURES AND AN EARLY MYELOID IMMUNOPHENOTYPE, Leukemia research, 21(6), 1997, pp. 575-580
Authors:
STASI R
BRUNETTI M
BUSSA S
CONFORTI M
MARTIN LS
LAPRESA M
BIANCHI M
PARMA A
PAGANO A
Citation: R. Stasi et al., SERUM LEVELS OF TUMOR-NECROSIS-FACTOR-ALPHA PREDICT RESPONSE TO RECOMBINANT-HUMAN-ERYTHROPOIETIN IN PATIENTS WITH MYELODYSPLASTIC SYNDROME, Clinical and laboratory haematology, 19(3), 1997, pp. 197-201
Authors:
STASI R
BRUNETTI M
PARMA A
CATUCCI AE
LEONI M
TERZOLI E
PAGANO A
Citation: R. Stasi et al., RESPONSE TO RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHEPO) AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (RHGM-CSF) IN PATIENTS WITH LOW-RISK MYELODYSPLASTIC SYNDROMES (MDSS), Blood, 90(10), 1997, pp. 364-364
Authors:
VENDITTI A
DELPOETA G
BUCCISANO F
TAMBURINI A
COX MC
STASI R
BRUNO A
ARONICA G
MAFFEI L
SUPPO G
SIMONE MD
FORTE L
CORDERO V
POSTORINO M
TUFILLI V
ISACCHI G
MASI M
PAPA G
AMADORI S
Citation: A. Venditti et al., MINIMALLY DIFFERENTIATED ACUTE MYELOID-LEUKEMIA (AML-MO) - COMPARISONOF 25 CASES WITH OTHER FRENCH-AMERICAN-BRITISH SUBTYPES, Blood, 89(2), 1997, pp. 621-629
Authors:
TAYLOR CG
STASI R
BASTIANELLI C
VENDITTI A
DELPOETA G
AMADORI S
SARGENT J
Citation: Cg. Taylor et al., DIAGNOSIS AND CLASSIFICATION OF THE ACUTE LEUKEMIAS - RECENT ADVANCESAND CONTROVERSIAL ISSUES, Hematopathology and molecular hematology, 10(1-2), 1996, pp. 1-38
Authors:
AMADORI S
VENDITTI A
DELPOETA G
STASI R
BUCCISANO F
BRUNO A
TAMBURINI A
COX MC
MAFFEI L
ARONICA G
SIMONE MD
ADORNO G
MASI M
TRIBALTO M
PAPA G
Citation: S. Amadori et al., MINIMALLY DIFFERENTIATED ACUTE MYELOID-LEUKEMIA (AML-MO) - A DISTINCTCLINICO-BIOLOGIC ENTITY WITH POOR-PROGNOSIS, Annals of hematology, 72(4), 1996, pp. 208-215
Authors:
LISO V
IACOPINO P
AVVISATI G
PETTI MC
BROCCIA G
CAROTENUTO M
FALDA M
FAZI P
LAZZARINO M
LEONI P
MIRTO S
PUCCI G
NOBILE F
NOSARI AM
SPECCHIA G
STASI R
TABILIO A
MANDELLI F
Citation: V. Liso et al., OUTCOME OF PATIENTS WITH ACUTE MYELOID-LEUKEMIA WHO FAILED TO RESPONDTO A SINGLE COURSE OF FIRST-LINE INDUCTION THERAPY - A GIMEMA STUDY OF 218 UNSELECTED CONSECUTIVE PATIENTS, Leukemia, 10(9), 1996, pp. 1443-1452
Authors:
BRUNETTI M
STASI R
CATUCCI A
BUSSA S
PAGANO A
Citation: M. Brunetti et al., HIGH-DOSE CYTOSINE-ARABINOSIDE IN ACUTE MYELOID-LEUKEMIA - RATIONALE AND RESULTS, The Cancer journal, 9(2), 1996, pp. 83-88
Authors:
STASI R
VENDITTI A
DELPOETA G
ARONICA G
DENTAMARO T
CECCONI M
STIPA E
SCIMO MT
MASI M
AMADORI S
Citation: R. Stasi et al., INTENSIVE TREATMENT OF PATIENTS AGE 60 YEARS AND OLDER WITH DE-NOVO ACUTE MYELOID-LEUKEMIA - ANALYSIS OF PROGNOSTIC FACTORS, Cancer, 77(12), 1996, pp. 2476-2488
Authors:
VENDITTI A
DELPOETA G
STASI R
BUCCISANO F
ARONICA G
BRUNO A
COX C
MAFFEI L
TAMBURINI A
PAPA G
AMADORI S
Citation: A. Venditti et al., BIOLOGICAL PROFILE OF 23 CASES OF MINIMALLY DIFFERENTIATED ACUTE MYELOID-LEUKEMIA (AML-MO) AND ITS CLINICAL IMPLICATIONS, Blood, 87(1), 1996, pp. 418-420
Authors:
STASI R
BRUNO A
VENDITTI A
DELPOETA G
COPPETELLI U
TRIBALTO M
PAPA G
Citation: R. Stasi et al., LEUKOCYTE ALKALINE-PHOSPHATASE SCORE IN PLASMA-CELL DYSCRASIAS - CORRELATION WITH DISEASE SEVERITY AND CIRCULATING LEVELS OF GRANULOCYTE-COLONY-STIMULATING FACTOR, Leukemia & lymphoma, 17(5-6), 1995, pp. 479-483